Google’s AMIE research AI moves from diagnosis to disease care
Google’s medical conversation AI system, AMIE, has moved in research from one-time diagnosis chats toward longer-term disease management. AMIE uses ’ ability to talk with patients in real time while also checking drug lists and . The study was published in Nature and used a blinded setup with patient actors.
Specialist doctors compared AMIE with 21 primary care doctors. AMIE matched the doctors on overall management reasoning and scored higher on how precise its care plans were and how well they followed . Google says this kind of AI could one day support doctors and give them more time with patients.
The next steps are testing how AMIE could work in clinical settings and running a nationwide study of AI in real-world virtual care.
Key points
- AMIE is Google’s research medical AI system for conversations and reasoning.
- The new work focuses on ongoing disease management, not just diagnosis.
- It uses ’ ability to combine patient dialogue with medical guidance.
- Specialist doctors compared AMIE with 21 primary care doctors in a blinded study.
- AMIE matched doctors on overall reasoning and scored higher on plan and guideline alignment.